While some studies have reported associations between the CYP3A4*1B allele and higher clinical grade of PCa [14], [15], others have failed to observe an association between the presence of the CYP3A4*1B polymorphism and prostate cancer susceptibility [16], [17]. Here, CYP3A4 is linked to prostate carcinoma.